Access to highly effective long-acting RSV-monoclonal antibodies for children in LMICs-reducing global inequity
Related Experiment Video
Updated: Jun 18, 2025

09:14
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
10.8K
Heather J Zar1, Manuele Piccolis2, Jonne Terstappen3
1Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa; South African Medical Research Council Unit on Child and Adolescent Health, University of Cape Town, Cape Town, South Africa.
The Lancet. Global Health
|July 27, 2024
Abstract
No abstract available in PubMed .

